Skip to content

Construction and Comparative study of preoperative frailty risk Prediction Model for gastric cancer patients based on XG Boost Algorithm and Random Forest

Construction and Comparative study of preoperative frailty risk Prediction Model for gastric cancer patients based on XG Boost Algorithm and Random Forest

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121634
Enrollment
Unknown
Registered
2026-04-01
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preoperative frailty of gastric cancer

Interventions

Gold Standard:The Frailty Phenotype (FP) is a hybrid measurement tool that combines subjective self-reporting and objective measurement. It involves the assessment of five aspects. One point is scored
early stage of frailty:1~2
frailty=3
Index test:Predictive Model for Preoperative Frailty Risk in Gastric Cancer Patients

Sponsors

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age >=18 years old; 2. Pathological or cytological diagnosis of primary gastric cancer; 3. Radical resection surgery is proposed; 4. No other treatment measures such as radiotherapy or chemotherapy were received before the operation; 5. Be conscious and have a certain cognitive level, capable of understanding the content of the questionnaire; 6. Voluntarily participate in this study and sign the informed consent form;

Exclusion criteria

Exclusion criteria: 1. Vulnerable groups other than the elderly and illiterates, including those with mental illnesses, cognitive impairments, critically ill patients, pregnant women, etc; 2. Those with impaired functions of important organs such as the heart, lungs, liver and kidneys; 3. Those who have experienced significant changes in their condition before the operation; 4. Those who are currently participating in other interventional clinical trials;

Design outcomes

Primary

MeasureTime frame
Frailty phenotype;

Secondary

MeasureTime frame
General Information;

Countries

China

Contacts

Public ContactXiaojie Zhang

Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University

zhangxiaojie@srrsh.com+86 571 8600 6951

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026